Moderna announces Hong Kong expansion

Its new subsidiary will provide a local presence for improved logistics.

Biotechnology company Moderna announced its plans to establish a new subsidiary in Hong Kong alongside Malaysia, Taiwan, and Singapore. With offices in Japan, South Korea, and Australia, Moderna continued its expansion to the Asia-Pacific (APAC) region.

"The year 2021 was a year of impact for Moderna, and I am proud to see continued growth in 2022 as we expand our presence in Asia. After a decade of pioneering the development of our mRNA platform, we were ready to play a critical role in combating the COVID-19 pandemic globally," said CEO Stéphane Bancel.

Moderna is actively recruiting a team to build a strong presence in the market as its mRNA therapeutics pipeline grows to benefit Hong Kong and the wider region.

It is currently is developing mRNA medicines to potentially prevent and treat diseases with significant unmet needs across infectious diseases, immuno-oncology, rare and ultra-rare diseases, and autoimmune diseases.

Follow the link for more news on

Moderna

expansion plans

Also Read

Gov't opens GBA International Clinical Trial Institute in Shenzhen Park

Hospital Authority and ZOC-SYSU partner to enhance ophthalmology services

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit